TIDES USA
TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio. It is the world’s largest gathering for those interested in accelerating oligonucleotide, peptide, mRNA and genome editing products from early discovery to late-stage development and commercialization.
The program features 4 concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing.
TIDES USA 2022 TRACKS:
- Oligonucleotide Chemistry, Manufacturing & Controls
- Oligonucleotide Discovery, Preclinical and Clinical
- Peptide Chemistry, Manufacturing & Controls
- Peptide Discovery, Preclinical and Clinical
- mRNA Therapeutics/Vaccines & Genome Editing
- Drug Delivery Innovations
Founded in 2015, Hzymes Biotechnology Co., Ltd. (Enzymes) is a high-tech enterprise specializing in the research and development, production, application and technical services of enzymes.
Contact
Hzymes Biotechnology Co., Ltd
- 021-60879177
- hzymes@hzymes.com
- Tower 3, Precision Medical Industry Base, Gaokeyuan 3rd Road,No.9, Wuhan, China
Wuhan Glycogene Pharmaceutical Co., Ltd.
- 1 614 886 5695
- info@glycogene.com
- Precision medical industry base,East Lake New Technology Development Zone, Wuhan,China